Vital Chemtech Ltd
Incorporated in 2014, Vital Chemtech Ltd manufactures and supplies phosphorous based chemicals[1]
- Market Cap ₹ 120 Cr.
- Current Price ₹ 50.0
- High / Low ₹ 75.7 / 48.1
- Stock P/E 38.8
- Book Value ₹ 38.9
- Dividend Yield 0.00 %
- ROCE 6.68 %
- ROE 4.60 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of 5.05% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 58 | 117 | 98 | 134 | 133 | |
| 46 | 102 | 98 | 123 | 121 | |
| Operating Profit | 12 | 15 | 0 | 11 | 11 |
| OPM % | 20% | 13% | 0% | 8% | 8% |
| 0 | 0 | 3 | 2 | 1 | |
| Interest | 0 | 1 | 1 | 2 | 2 |
| Depreciation | 1 | 2 | 3 | 5 | 5 |
| Profit before tax | 11 | 11 | -0 | 6 | 5 |
| Tax % | 26% | 30% | 269% | 35% | |
| 8 | 8 | -1 | 4 | 3 | |
| EPS in Rs | 11.75 | 3.36 | -0.54 | 1.70 | 1.29 |
| Dividend Payout % | 0% | 15% | -92% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 32% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -20% |
| TTM: | 464% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -21% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 5% |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 7 | 24 | 24 | 24 | 24 |
| Reserves | 8 | 66 | 60 | 68 | 69 |
| 36 | 29 | 26 | 48 | 66 | |
| 30 | 19 | 27 | 41 | 33 | |
| Total Liabilities | 81 | 138 | 137 | 182 | 193 |
| 17 | 25 | 43 | 68 | 39 | |
| CWIP | 0 | 0 | 0 | 15 | 54 |
| Investments | 3 | 15 | 35 | 20 | 14 |
| 61 | 98 | 60 | 78 | 86 | |
| Total Assets | 81 | 138 | 137 | 182 | 193 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -13 | -8 | 14 | 6 | |
| 1 | -26 | -35 | -30 | |
| 18 | 58 | -9 | 25 | |
| Net Cash Flow | 6 | 24 | -30 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 264 | 120 | 146 | 128 |
| Inventory Days | 87 | 57 | 61 | 47 |
| Days Payable | 265 | 65 | 111 | 121 |
| Cash Conversion Cycle | 87 | 112 | 96 | 54 |
| Working Capital Days | 59 | 116 | 78 | 72 |
| ROCE % | 15% | 0% | 7% |
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
8 January 2026 - RTA certificate under SEBI Regulation 74(5) confirming compliance for quarter ended 31 December 2025.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
8 January 2026 - Company claims non-applicability of Reg.27(2) filing for quarter ended Dec 31, 2025 under Reg.15(2)(b) exemption.
-
Shareholders meeting
22 December 2025 - Migrated listing from NSE Emerge to NSE main and BSE; special resolution passed with 615,600 votes (100%)
-
Shareholders meeting
22 December 2025 - Postal ballot (21-Dec-2025): shareholders approved migration to NSE mainboard and BSE; 615,600 votes (100%) in favour.
-
Copy of Newspaper Publication
22 November 2025 - Postal Ballot Notice advertisement published November 22, 2025 in Financial Express (English and Gujarati).
Business Overview:[1][2]
VCL is a part of Vital Group which is a multi-product organization involved in Manufacturing, Contract Manufacturing and Exports of Chemicals. Company does manufacturing and supplying of Phosphorus Derivatives Products and Phosphorus base chemicals. It also does trading of its raw Material and is in the process of obtaining approval of Phosphorus Pentasulfide (P2S5)